Back to search
FDAFDA · Food and drugs·Recall number D-1160-2016

HEPARIN Sodium in 0.45% Sodium Chloride, 1 USP Unit/2 mL (0.5 USP Units/mL), Rx Only, Cantrell Drug Co., Little Rock, AR --- NDC 52533-148-16, UPC: 0100352533148163

Published July 13, 2016 · Recall initiated: August 21, 2015

Summary

FDA records drug Class II recall D-1160-2016, published July 13, 2016 and initiated August 21, 2015. Recalling firm: Cantrell Drug Company; Status: Terminated; Reported quantity: 4170 syringes; Lot: Lot: 6146, exp 9/5/15. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Stability Data Does Not Support Expiry

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Cantrell Drug Company
Distributor
Nationwide
UPC
01003525331481
Lot
Lot: 6146, exp 9/5/15
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was HEPARIN Sodium in 0.45% Sodium Chloride, 1 USP Unit/2 mL (0.5 USP Units/mL), Rx Only, Cantrell Drug Co., Little Rock, AR --- NDC 52533-148-16, UPC: 0100352533148163 recalled?

Yes. FDA published recall D-1160-2016 on July 13, 2016. Reported hazard: Stability Data Does Not Support Expiry

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail

How do I know if my unit is part of the recall?

Compare your product details with the notice. UPC: 01003525331481.